Renalytix reverts to foreign private issuer SEC filing status effective Jan 1, 2025

Renalytix plc

Company determined it qualifies as FPI as of Dec 31, 2024; will cease domestic issuer filings.
Effective Jan 1, 2025, Renalytix will file periodic reports using FPI forms.
Company had previously been an FPI but filed as domestic since July 1, 2023.
Change may reduce SEC reporting burden (e.g., no quarterly 10-Q, different GAAP allowed).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.